Dr. Todd Ernest Falcone, MD

Dr. Falcone practices at Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut.

Dr. Falcone's NPI, 1952538456, was assigned on June 11, 2009. Dr. Falcone graduated from Uconn School Of Medicine in 2009. Dr. Falcone holds Connecticut license 52871.

Dr. Falcone's primary practice is Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD, at 263 Farmington Ave, Farmington, CT 06030.

Dr. Falcone's primary practice is Uconn Health Carole and Ray Neag Comprehensive Cancer Center - HOPD in Farmington, Connecticut. Dr. Falcone is also affiliated with UConn John Dempsey Hospital. The medical group on file is UConn Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Falcone practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Falcone's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Falcone is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Falcone's licenses on file in 2 states: Connecticut and Massachusetts.

Dmand AI lists chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and swimmer's ear among the conditions Dr. Falcone treats.

CMS data shows 321 Medicare services from Dr. Falcone across 8 procedure codes in 2024, for 182 Medicare patients. Medicare paid $25,741 for them. Every service was in an office.

CMS counts 182 Medicare patients who saw Dr. Falcone in 2024. The largest group is 65 to 74, with 76 patients. 65% of them have high cholesterol, and 59% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Falcone's median patient age at 68, with 54% women.

In 2024, Dr. Falcone wrote 508 Medicare Part D claims for 197 patients. 93% of them were for generic drugs. CMS names the drug for 424 of them, across 11 drugs with 11 or more claims each, at $118,020 in total drug cost. In 2023, CMS named 432 claims across 12 drugs.

Dr. Falcone accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 23 papers to Dr. Falcone, published from 2014 to 2023. 2020 was the busiest year, with 5. The most frequent topics are Otolaryngology, Ethmoid Sinus and Tomography, X-Ray Computed. Dr. Falcone has published most often in Ear Nose Throat J. Dr. Falcone's most frequent co-authors are Marissa A. Schwartz, MD, Katherine Reichmann Kavanagh, MD and Kathryn L. Kreicher, MD.

CMS Open Payments shows 20 general payments to Dr. Falcone from 5 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 81% of the total. Medtronic, Inc. paid the most, $6,294.

Dmand AI lists 1 award for Dr. Falcone.

Dr. Falcone graduated from Uconn School Of Medicine in 2009. Dr. Falcone is a member of NHS.

Dr. Falcone is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.